ScholarLens Back to search
2007•Medical Journal of National Defending Forces in Northwest ChinaRequires access

Application of Transurethral Bipolar Plasmakinetic Vaporization and Resection of the Prostate(TUPKVP) in the treatment of 580 cases of benign prostatic hyperplasia

Hong Liu

Open publisher page 0 citations

Abstract

Objective:To evaluate the efficacy of transurethral bipolar plasmakinetic vaporization and resection of the prostate(TUPKVP) in the treatment of benign prostatic hyperplasia(BPH).Methods: The clinical data of 580 patients with BPH who underwent TUPKVP was analyzed retrospectively.Results: 2 cases were converted to open surgery.The weight of the resected prostate was 10～80 g,averaged 32.5 g.The operation time was 20～150 min,with an average of 60min.10 cases needed blood transfusion during the operation and no transurethral resection syndrom(TURS)occurred.The follow-up time was 2～36 months.The improvement of IPSS and peak flow rate(Qmax) were observed.Therapeutic effect was satisfactory with smooth urination and fewer complications.Conclusion: TUPKVP is effective in the treatment of BPH,which is safer and causes little blood loss.

About this research paper

What this paper is about

Objective:To evaluate the efficacy of transurethral bipolar plasmakinetic vaporization and resection of the prostate(TUPKVP) in the treatment of benign prostatic hyperplasia(BPH).Methods: The clinical data of 580 patients with BPH who underwent TUPKVP was analyzed retrospectively.Results: 2 cases were converted to open surgery.The weight of the resected prostate was 10～80 g,averaged 32.5 g.The operation time was 20～150 min,with an average of 60min.10 cases needed blood transfusion during the operation and no transurethral resection syndrom(TURS)occurred.The follow-up time was 2～36 months.The improvement of IPSS and peak flow rate(Qmax) were observed.Therapeutic effect was satisfactory with smooth urination and fewer complications.Conclusion: TUPKVP is effective in the treatment of BPH,which is safer and causes little blood loss.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the efficacy of transurethral bipolar plasmakinetic vaporization and resection of the prostate(TUPKVP) in the treatment of benign prostatic hyperplasia(BPH).Methods: The clinical data of 580 patients with BPH who underwent TUPKVP was analyzed retrospectively.Results: 2 cases were converted to open surgery.The weight of the resected prostate was 10～80 g,averaged 32.5 g.The operation time was 20～150 min,with an average of 60min.10 cases needed blood transfusion during the operation and no transurethral resection syndrom(TURS)occurred.The follow-up time was 2～36 months.The improvement of IPSS and peak flow rate(Qmax) were observed.Therapeutic effect was satisfactory with smooth urination and fewer complications.Conclusion: TUPKVP is effective in the treatment of BPH,which is safer and causes little blood loss.

Key concepts: Medicine, Hyperplasia, Urology, Prostate, Urination, Blood transfusion, Blood loss, Resection

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Application of Transurethral Bipolar Plasmakinetic Vaporization and Resection of the Prostate(TUPKVP) in the treatment of 580 cases of benign prostatic hyperplasia — Research Paper | ScholarLens